NCT01923181 · Interventional trial
Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes
Overall registry status Completed
Phase 2
Conditions Diabetes, Diabetes Mellitus, Type 2
Delaware Valley sites
- Novo Nordisk Investigational Site · Philadelphia, PA · Philadelphia County
- Novo Nordisk Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory